These advancements are providing women with options to safeguard their fertility while facing cancer.

Gynaecological cancer treatment presents a formidable challenge for women of reproductive age, due the impact on their fertility. The primary modalities of treatment, including surgery, chemotherapy, and radiotherapy for ovarian, cervical, and endometrial cancers, often anatomically or functionally affect the uterus and ovaries. Beyond the physical toll, the diagnosis of cancer takes a toll on the sexual function and psychological wellbeing of patients, leading to concerns about depression, anxiety, and a diminished quality of life.

Fertility Preservation:

For many women, the potential loss of fertility becomes a distressing aspect of their cancer journey, sometimes overshadowing the gravity of the disease itself. Recognising this, there is an increasing emphasis on the importance of preserving fertility in women affected by gynaecological cancers.

Utilising personalized fertility preservation therapies, individuals between the ages of 18 and 40 who have been diagnosed with cancer are provided with choices to protect their fertility while undergoing treatment.

Find out more:

Mr Saurabh Phadnis recognises that fertility preservation is more than just a medical concern; it involves a comprehensive approach that addresses the physical, emotional, and psychological aspects of patients – which brings together medical professionals, counsellors, and support staff to provide holistic care.

Their collective goal is to empower women facing gynaecological cancer, enabling them to make well-informed decisions about their reproductive health.

Through collaborative efforts, we aim to support our patients throughout their journey, considering not only the medical treatments but also the emotional and psychological impact of their experience. By championing this multidisciplinary approach, we aspire to enhance the overall quality of life for women both during and after cancer treatment.